The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes

Thrombosis Research

Volumn 120, Issue 6, 2007, Pages 877-884

  Fürstenau, Cristina R ^a   Trentin, Danielle S ^a   Barreto Chaves, Maria Luiza M ^b   Sarkis, João J F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adenosine; Angiotensin II; E NPP; E NTPDase; Hypertension; Platelet

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; LOSARTAN; LOSARTAN POTASSIUM; NUCLEOTIDASE; NUCLEOTIDE; THROMBOCYTE ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; EXTRACELLULAR SPACE; HEREDITARY HYPERTENSION; HYDROLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; ANIMALS; BLOOD PLATELETS; ENZYME ACTIVATION; HYDROLYSIS; HYPERTENSION; MALE; PHENOTYPE; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, INBRED SHR; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; THYMIDINE MONOPHOSPHATE; VASOCONSTRICTOR AGENTS;

EID: 34548677052     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.01.006     Document Type: Article

References (43)

1. 2Y purinoceptors?. Pharmacol Ther 64 (1994) 445-475
2. Coukell A.J., and Markham A. Clopidogrel. Drugs 54 (1997) 745-750
3. Coade S.B., and Pearson J.D. Metabolism of adenine nucleotides in human blood. Circ Res 65 (1989) 531-537
4. Shryock J.C., and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology and pharmacology. Am J Cardiol 79 (1997) 2-10
5. Marcus A.J., Broekman M.J., Drosopoulos J.H.F., Islam N., Pinsky D.J., Sesti C., et al. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 305 (2003) 09-16
6. Blann A.D., Nadar S., and Lip G.Y.H. Hypertension 42 (2003) 1-7
7. Crabos M., Bertschin S., Buhler F.R., Rogg H., Evequoz D., Eberhard M., et al. Identification of AT1 receptors on human platelets and decreased angiotensin II binding in hypertension. J Hypertens S11 (1993) 230-231
8. Akdemir R., Özhan H., Yazici M., Gunduz H., Duran S., Gurel C., et al. In vivo effect of losartan on platelet aggregation in patients with hypertension. Heart Vessels 19 (2004) 167-171
9. Pravenec M., Kunes J., Zicha J., Kren V., and Klir P. Platelet aggregation in spontaneous hypertension: genetic determination and correlation analysis. J Hypertens 10 (1992) 1453-1456
10. Riondino S., Pignatelli P., Pulcinelli F.M., Lenti L., Di Veroli C., Marigliano V., et al. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure. J Am Geriatr Soc 47 (1999) 943-947
11. Erne P., Bolli P., Burgisser E., and Buhler F.R. Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med 310 (1984) 1084-1088
12. Larsson P.T., Schwieler J.H., and Wallen N.H. Platelet activation during angiotensin II infusion in healthy volunteers. Blood Coagul Fibrinolysis 11 (2000) 61-69
13. Brown N.J., and Vaughan D.E. Prothrombotic effects of angiotensin. Adv Intern Med 45 (2000) 419-429
14. Albino-Teixeira A., Matias A., Polónia J., and Azevedo L. Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J Hypertens S9 (1991) 196-197
15. Goldenberg I., Shainberg A., Kenneth A.J., Shneyvays V., and Grossman E. Adenosine protects against angiotensin II-induced apoptosis in rat cardiocyte cultures. Mol Cell Biochem 252 (2003) 133-139
16. Sousa T., Morato M., and Albino-Teixeira A. Angiotensin converting enzyme prevents trophic and hypertensive effects of an antagonist of adenosine receptors. Eur J Pharmacol 441 (2002) 99-104
17. Frassetto S.S., Dias R.D., and Sarkis J.J.F. Characterization of an ATP diphosphohydrolase activity (EC 3.6.1.5) in rat blood platelets. Mol Cell Biochem 129 (1993) 47-55
18. Fürstenau C.R., Trentin D.S., Barreto-Chaves M.L.M., and Sarkis J.J.F. Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 17 (2006) 84-91
19. Álvarez A., Cerdá-Nicolás M., Nabah Y.N.A., Mata M., Issekutz A.C., Panés A., et al. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 104 (2004) 402-408
20. Hu L.W., Benvenuti L.A., Liberti E.A., Carneiro-Ramos M.S., and Barreto-Chaves M.L.M. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus rennin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol 285 (2003) 1473-1480
21. Hantgan R.R. A study of the kinetic ADP-triggered platelet shape change. Blood 64 (1984) 806-906
22. Tangen O., Berman H.J., and Marfey P. A new technique for separation of blood platelets from plasma. Thromb Diath Haemorrh 25 (1971) 268-278
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
24. 2+-ATPase activity. Anal Biochem 157 (1986) 375-380
25. Sakura H., Nagashima S., Nakahima A., and Maeda M. Characterization of fetal serum 5′-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91 (1998) 83-89
26. Bhatt D.L., and Topol E.J. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev 2 (2002) 15-28
27. Boeynaems J.M., and Pearson J.D. P2 purinoceptors on vascular endothelial cells: physiology significance and transduction mechanisms. Trends Pharmacol Sci 11 (1990) 34-37
28. Dubyak G.R., and El-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265 (1993) 577-606
29. Qawi I., and Robson S.C. New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. Curr Drug Targets 1 (2000) 285-296
30. Marcus A.J., and Safier L.B. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. ASEB J 7 (1993) 516-522
31. Bakker W.W., Poelstra A., Barradas K., and Mikhailidis M.A. Platelets and ectonucleotidases. Platelets 5 (1994) 121-129
32. Robson S.C., Sévigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2 (2006) 409-430
33. Heine P., Braun N., Heilbronn A., and Zimmermann H. Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. Eur J Biochem 262 (1999) 102-107
34. Kukulski F., and Komoszynski M. Purification and characterization of NTPDase 1 (ecto-apyrase) and NTPDase 2 (ecto-ATPase) from porcine brain cortex synaptosomes. Eur J Biochem 270 (2003) 3447-3454
35. Oses J.P., Cardoso C.M., Germano R.A., Kirst I.B., Rücker B., Fürstenau C.R., et al. Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sci 74 (2004) 3275-3284
36. Moore T.J., Taylor T., and Williams G.H. Human platelet angiotensin II receptors: regulation by the circulating angiotensin level. J Clin Endocrinol Metab 58 (1984) 778-782
37. Keidar S., Attias J., Heinrich R., Coleman R., and Aviram M. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis 146 (1999) 249-257
38. Silbernagl S., and Despopoulos A. Fisiologia - texto e atlas (2003), Artmed, Porto Alegre 184
39. Ferreira A.J., and Santos R.A.S. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 38 (2005) 499-507
40. Jackson E.K. Adenosine: a physiological brake on renine release. Annu Rev Pharmacol Toxicol 31 (1991) 1-35
41. 1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance. Diabetes Obes Metab 3 (2001) 360-366
42. Okamoto K. Spontaneous hypertension in rats. International review of experimental pathology (1969), Academic Press, New York 227-270
43. 2B receptors. Hellenic J Cardiol 45 (2004) 65-70